TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 63 filers reported holding TCR2 THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,056,473 | +50.2% | 3,370,982 | 0.0% | 1.31% | +50.3% |
| Q4 2022 | $3,367,611 | -44.5% | 3,370,982 | 0.0% | 0.87% | -39.2% |
| Q3 2022 | $6,068,000 | -37.9% | 3,370,982 | 0.0% | 1.44% | -47.1% |
| Q2 2022 | $9,776,000 | +5.1% | 3,370,982 | 0.0% | 2.72% | +8.8% |
| Q1 2022 | $9,304,000 | -40.8% | 3,370,982 | 0.0% | 2.50% | -12.8% |
| Q4 2021 | $15,709,000 | -45.2% | 3,370,982 | 0.0% | 2.86% | -35.6% |
| Q3 2021 | $28,687,000 | -48.1% | 3,370,982 | 0.0% | 4.45% | -51.0% |
| Q2 2021 | $55,318,000 | -25.7% | 3,370,982 | 0.0% | 9.09% | -2.8% |
| Q1 2021 | $74,431,000 | -64.3% | 3,370,982 | -50.0% | 9.35% | -48.1% |
| Q4 2020 | $208,528,000 | +204.4% | 6,741,964 | +100.0% | 18.01% | +9.1% |
| Q3 2020 | $68,498,000 | +32.3% | 3,370,982 | 0.0% | 16.50% | +19.9% |
| Q2 2020 | $51,778,000 | +98.5% | 3,370,982 | 0.0% | 13.77% | -13.6% |
| Q1 2020 | $26,091,000 | -45.8% | 3,370,982 | 0.0% | 15.94% | -6.6% |
| Q4 2019 | $48,138,000 | – | 3,370,982 | – | 17.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
| MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
| Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
| HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
| Artal Group S.A. | 750,000 | $749 | 0.04% |
| Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
| Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
| X-Square Capital, LLC | 31,919 | $32 | 0.02% |
| CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |